Lista de obras -

A bacteriophage journey at the European Medicines Agency

artículo científico

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium

artículo científico publicado en 2015

Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation

artículo científico publicado en 2010

Bacteriophage Production in Compliance with Regulatory Requirements

artículo científico publicado en 2018

Beware of the commercialization of human cells and tissues: situation in the European Union

artículo científico publicado en 2012

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

article

Biosimilars and market access: a question of comparability and costs? ⬇️

artículo científico publicado el 17 de enero de 2012

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems

artículo científico publicado en 2013

Call for a dedicated European legal framework for bacteriophage therapy.

artículo científico publicado en 2014

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

artículo científico publicado en 2014

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

article

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

scientific article published on 25 September 2019

European regulatory conundrum of phage therapy

artículo científico publicado en 2007

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures

artículo científico publicado en 2011

Experimental phage therapy of burn wound infection: difficult first steps

artículo científico publicado en 2014

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

artículo científico publicado en 2018

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety

artículo científico publicado en 2011

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi

artículo científico publicado en 2011

Human cells and tissues: the need for a global ethical framework

artículo científico publicado en 2010

Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting

artículo científico publicado en 2013

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center

artículo científico publicado en 2016

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

artículo científico

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

artículo científico publicado en 2013

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation.

artículo científico publicado en 2010

Quality and safety requirements for sustainable phage therapy products

artículo científico publicado en 2015

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

artículo científico publicado en 2009

Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomography.

artículo científico publicado en 2014

Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomography.

artículo científico publicado en 2015

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

artículo científico publicado en 2012

Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)

artículo científico publicado en 2013

Stability of bacteriophages in burn wound care products.

artículo científico publicado en 2017

Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger

scientific article published on 27 August 2020

Taking bacteriophage therapy seriously: a moral argument

artículo científico publicado en 2014

The Magistral Phage

artículo científico publicado en 2018

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

artículo científico publicado en 2010

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

scientific article published on 03 September 2020

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report.

artículo científico publicado en 2017

Lista de obras de

A bacteriophage journey at the European Medicines Agency

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium

Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation

Bacteriophage Production in Compliance with Regulatory Requirements

Beware of the commercialization of human cells and tissues: situation in the European Union

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

Biosimilars and market access: a question of comparability and costs? ⬇️

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems

Call for a dedicated European legal framework for bacteriophage therapy.

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

European regulatory conundrum of phage therapy

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures

Experimental phage therapy of burn wound infection: difficult first steps

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi

Human cells and tissues: the need for a global ethical framework

Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation.

Quality and safety requirements for sustainable phage therapy products

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomography.

Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomography.

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)

Stability of bacteriophages in burn wound care products.

Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger

Taking bacteriophage therapy seriously: a moral argument

The Magistral Phage

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report.